Amundi United Therapeutics Corp Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in United Therapeutics Corp stock. As of the latest transaction made, Amundi holds 65,320 shares of UTHR stock, worth $24.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

65,320

Previous 472,992 86.19%

Holding current value

$24.1 Million

Previous $151 Million 84.46%

% of portfolio

0.01%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$311.04 - $363.55 $127 Million - $148 Million	-407,672 Reduced 86.19%	65,320 $23.4 Million
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $70.3 Million - $98.3 Million	307,962 Added 186.61%	472,992 $151 Million
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $5.15 Million - $6.1 Million	-24,434 Reduced 12.9%	165,030 $37.9 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $10.3 Million - $12.4 Million	48,150 Added 34.07%	189,464 $41.7 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $18.6 Million - $21.8 Million	87,931 Added 164.72%	141,314 $31.9 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $5.78 Million - $6.56 Million	28,161 Added 111.65%	53,383 $11.8 Million
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $952,278 - $1.23 Million	-4,471 Reduced 15.06%	25,222 $5.65 Million
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $5.8 Million - $7.89 Million	28,146 Added 1819.39%	29,693 $8.26 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $3,659 - $4,395	18 Added 1.18%	1,547 $328,000
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $35,661 - $49,192	-204 Reduced 11.77%	1,529 $363,000
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $24,425 - $31,452	-147 Reduced 7.82%	1,733 $329,000
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $320,483 - $398,428	1,880 New	1,880 $337,000

Others Institutions Holding UTHR

# of Institutions

672

Shares Held

42.4M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.8B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account